Excipients without active substance clinical trials

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Dose-Titrated PLS240 in the Treatment of Secondary Hyperparathyroidism in Individuals with End Stage Kidney Disease on Hemodialysis (PATH-2) With an Open-Label Extension

This study is testing a new medicine, PLS240, for people with serious kidney disease on dialysis. It aims to see if PLS240 can help control a hormone called PTH and if it's safe to use. Patients will either get PLS240 or a dummy pill.